KimS
New Member
Hello,
I apologize for the lateness in submitting the question. I have a dilemma when coding for diagnostic services for an oncology service. When a yearly evaluation is being done, the physicians are assigning acute cancer codes for conditions that should clearly be a history. If a patient has had a mastectomy to remove the cancer, has had normal mammograms, and the physician states in his H&P that there is NED, shouldn't a history of breast cancer be coded. There are many times when the patient is receiving an aromatase inhibitor or a selective estrogen-receptor modulator (SERM), and I am wondering if the physician is considering their use as treatment of the breast cancer. Would it be appropriate to assign an acute cancer code when the patient is receiving the mentioned pharmaceuticals?
Thanks for your replies!
Kim
I apologize for the lateness in submitting the question. I have a dilemma when coding for diagnostic services for an oncology service. When a yearly evaluation is being done, the physicians are assigning acute cancer codes for conditions that should clearly be a history. If a patient has had a mastectomy to remove the cancer, has had normal mammograms, and the physician states in his H&P that there is NED, shouldn't a history of breast cancer be coded. There are many times when the patient is receiving an aromatase inhibitor or a selective estrogen-receptor modulator (SERM), and I am wondering if the physician is considering their use as treatment of the breast cancer. Would it be appropriate to assign an acute cancer code when the patient is receiving the mentioned pharmaceuticals?
Thanks for your replies!
Kim